Videos

Yi-Bin Chen, MD, provides insight into the latest FDA approvals for the treatment of patients with acute and chronic graft-versus-host disease.

Rajiv Agarwal, MD, discusses how to best provide palliative care for patients with gastrointestinal cancers, a topic he presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies virtual meeting.

Ghassan Abou-Alfa, MD, shares insights about the recent FDA approval of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma and discusses findings from the HIMALAYA trial, which led to the approval.

Lyudmila Bazhenova, MD, discusses targeted therapy for MET-dependent lung cancers, a topic she presented at the 2022 Great Debates & Updates in Lung Cancer meeting in New York.

Kristin Higgins, MD, provides an overview on the current and future treatment of small cell lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung Cancers meeting in New York.

Matthew Matasar, MD, discusses a phase 2 study assessing the safety and efficacy of fixed-duration mosunetuzumab, a CD20-CD3 T-cell-engaging bispecific monoclonal antibody, for relapsed/refractory follicular lymphoma.

Tim Pawlik, MD, explains how he and colleagues used landmark analysis to develop a prognostic model that provides a more dynamic prediction of long-term outcomes for patients undergoing curative-intent surgery for intrahepatic...

Jean-Pascal Machiels, MD, discusses results from the phase 3 KEYNOTE-412 trial showing the addition of pembrolizumab to chemoradiotherapy is associated with a favorable trend toward improved EFS for patients with locally advanced head and...

Kathleen Moore, MD, gives an overview on recent developments in treatments for advanced stage ovarian cancer, a topic she presented at the 2022 GDU Women’s Oncology virtual meeting.

Helena Yu, MD, discusses the treatment of patients with early-stage EGFR-mutated lung cancer with a focus on improving overall survival, a topic she presented at the 2022 Great Debates and Updates in Lung Cancer meeting in New York.